Fusing two immune system proteins leads to a new method of generating antibodies
The Food and Drug Administration has approved more than 100 monoclonal antibodies to treat a range of diseases. Other ...
News-Medical.Net on MSN3d
New monoclonal antibody shows promise in treating mucormycosis
Mucormycosis, a fungal infection caused by Mucorales, has high mortality rates in people with weakened immune systems and those suffering from severe trauma like burns, blast injuries or victims of ...
Tharimmune Announces Positive Results for Novel Oral Monoclonal Antibody TH023 Targeting Tumor Necrosis Factor-alpha
Tharimmune, Inc. (Nasdaq:THAR) (”Tharimmune” or the “Company”), a clinical-stage biotechnology company focused on immunology and inflammation, today announced positive preclinical results for its ...
Healio1d
RNA sequencing uncovers more than 60 monoclonal antibodies linked to alpha-gal syndrome
An antibody discovery platform revealed more than 60 monoclonal antibodies specific to patients with alpha-gal syndrome, ...
American Association of Individual Investors1d
Why Zenas BioPharma, Inc.’s (ZBIO) Stock Is Up 11.76%
Zenas BioPharma, Inc.’s ZBIO share price has surged by 11.76%, which has investors questioning if this is right time to sell.
Charlotte Observer1d
Tharimmune Announces Positive Results for Novel Oral Monoclonal Antibody TH023 Targeting Tumor Necrosis Factor-alpha
The Company announced last year through a partnership with Intract Pharma, an exclusive license to INT-023 (now TH023), an oral anti-TNF-α monoclonal antibody. Tharimmune licensed global ...